Literature DB >> 20189442

Molecular analysis of surgical margins in head and neck cancer: more than a marginal issue.

Boudewijn J M Braakhuis1, Elisabeth Bloemena, C René Leemans, Ruud H Brakenhoff.   

Abstract

The relatively modest survival of patients surgically treated for advanced HNSCC can partly be explained by the development of local relapse. It is important that surgeons are able to predict which patients are at high risk to develop local relapse, since clinical management can be tailored. Local relapse after resection of a primary HNSCC is easily explained, when tumour is detected in the surgical margins and thus residual tumour is likely to remain in the patient, but the pathobiology is more complex in cases where the margins are histologically tumour-free. Molecular studies indicate that there are two different mechanisms responsible in these cases. First, small clusters of residual tumour cells that are undetectable on routine histopathological examination (known as minimal residual cancer: MRC) proliferate and this forms the basis of recurring cancer. A second cause of relapse is a remaining field of preneoplastic cells that is struck by additional genetic hits leading to invasive cancer. It is likely that within this field, that can be over 7cm in diameter, the primary carcinoma has also emerged. Despite careful histopathological examination of the surgical margins of the primary carcinoma, it is at present not reliably possible to predict which patient will develop local relapse. Herein we focus on new developments regarding the analysis of margins, causes of local relapse, and how novel molecular techniques can be of help in a more accurate risk assessment. Critical analysis of the studies that have been published thus far shows that there is a list of promising markers, based on protein expression (immuno-histochemistry) and nucleic acid analysis. Further studies should be focused on validation and assessment of the clinical utility of these markers. Margin analysis should reveal whether one is dealing with residual cancer cells that might be treated by post-operative radiotherapy or with preneoplastic fields that remained behind. For this latter entity, there is no intervention available at present, except for a more intensive surveillance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20189442     DOI: 10.1016/j.oraloncology.2010.01.019

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  27 in total

1.  Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence.

Authors:  Federica Ganci; Andrea Sacconi; Valentina Manciocco; Renato Covello; Maria Benevolo; Francesca Rollo; Sabrina Strano; Sara Valsoni; Silvio Bicciato; Giuseppe Spriano; Paola Muti; Giulia Fontemaggi; Giovanni Blandino
Journal:  Mod Pathol       Date:  2017-07-21       Impact factor: 7.842

2.  Design and characterization of a handheld multimodal imaging device for the assessment of oral epithelial lesions.

Authors:  Laura M Higgins; Mark C Pierce
Journal:  J Biomed Opt       Date:  2014-08       Impact factor: 3.170

3.  Deletion of macrophage migration inhibitory factor inhibits murine oral carcinogenesis: Potential role for chronic pro-inflammatory immune mediators.

Authors:  Steve Oghumu; Thomas J Knobloch; Cesar Terrazas; Sanjay Varikuti; Jennifer Ahn-Jarvis; Claire E Bollinger; Hans Iwenofu; Christopher M Weghorst; Abhay R Satoskar
Journal:  Int J Cancer       Date:  2016-06-16       Impact factor: 7.396

4.  Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management.

Authors:  Ilda Patrícia Ribeiro; Francisco Marques; Francisco Caramelo; João Pereira; Miguel Patrício; Hugo Prazeres; José Ferrão; Maria José Julião; Miguel Castelo-Branco; Joana Barbosa de Melo; Isabel Poiares Baptista; Isabel Marques Carreira
Journal:  Cell Oncol (Dordr)       Date:  2013-12-19       Impact factor: 6.730

Review 5.  Surgical margins and its evaluation in oral cancer: a review.

Authors:  Spoorthi Banvar Ravi; Saileela Annavajjula
Journal:  J Clin Diagn Res       Date:  2014-09-20

6.  Expression of p53, Ki-67 and c-Myc proteins is predictive of the surgical molecular margin in colorectal carcinoma.

Authors:  Nan Li; Jingmei Wang; Shanshan Shen; Xiaodong Bu; Xiaoqiang Tian; Peilin Huang
Journal:  Pathol Oncol Res       Date:  2011-02-05       Impact factor: 3.201

7.  The histologic risk model is a useful and inexpensive tool to assess risk of recurrence and death in stage I or II squamous cell carcinoma of tongue and floor of mouth.

Authors:  Namita Sinha; Matthew H Rigby; Michael L McNeil; S Mark Taylor; Jonathan Rb Trites; Robert D Hart; Martin J Bullock
Journal:  Mod Pathol       Date:  2018-02-02       Impact factor: 7.842

8.  Histologic and systemic prognosticators for local control and survival in margin-negative transoral laser microsurgery treated oral cavity squamous cell carcinoma.

Authors:  Parul Sinha; Mitra Mehrad; Rebecca D Chernock; James S Lewis; Samir K El-Mofty; Ningying Wu; Brian Nussenbaum; Bruce H Haughey
Journal:  Head Neck       Date:  2014-01-16       Impact factor: 3.147

Review 9.  Determining Adequate Margins in Head and Neck Cancers: Practice and Continued Challenges.

Authors:  Michelle D Williams
Journal:  Curr Oncol Rep       Date:  2016-09       Impact factor: 5.075

Review 10.  The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.

Authors:  Lindsey E Romick-Rosendale; Vivian W Y Lui; Jennifer R Grandis; Susanne I Wells
Journal:  Mutat Res       Date:  2013-01-17       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.